Mammalian target of rapamycin complex 2 modulates αβTCRB processing and surface expression during thymocyte development

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1162-1170

  Chou, Po Chien ^a   Oh, Won Jun ^a   Wu, Chang Chih ^a   Moloughney, Joseph ^a   Ruegg, Markus A ^b   Hall, Michael N ^b   Jacinto, Estela ^a   Werlen, Guy ^c  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA TOLL LIKE RECEPTOR; CD147 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; NOTCH RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; GLYCOSYLATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; JURKAT CELLS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 84906085545     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303162     Document Type: Article

References (35)

1. Jewell, J. L., and K. L. Guan. 2013. Nutrient signaling to mTOR and cell growth. Trends Biochem. Sci. 38: 233-242.
2. Yang, K., and H. Chi. 2012. mTOR and metabolic pathways in T cell quiescence and functional activation. Semin. Immunol. 24: 421-428.
3. Oh, W. J., C. C. Wu, S. J. Kim, V. Facchinetti, L. A. Julien, M. Finlan, P. P. Roux, B. Su, and E. Jacinto. 2010. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29: 3939-3951.
4. Dai, N., J. Christiansen, F. C. Nielsen, and J. Avruch. 2013. mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts. Genes Dev. 27: 301-312.
5. Waickman, A. T., and J. D. Powell. 2012. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol. Rev. 249: 43-58.
6. Tang, F., Q. Wu, T. Ikenoue, K. L. Guan, Y. Liu, and P. Zheng. 2012. A critical role for Rictor in T lymphopoiesis. J. Immunol. 189: 1850-1857.
7. Lee, K., K. T. Nam, S. H. Cho, P. Gudapati, Y. Hwang, D. S. Park, R. Potter, J. Chen, E. Volanakis, and M. Boothby. 2012. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J. Exp. Med. 209: 713-728.
8. Bhandoola, A., H. von Boehmer, H. T. Petrie, and J. C. Zúñiga-Pflücker. 2007. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity 26: 678-689.
9. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2: 309-322.
10. Werlen, G., B. Hausmann, D. Naeher, and E. Palmer. 2003. Signaling life and death in the thymus: timing is everything. Science 299: 1859-1863.
11. Renno, T., A. Wilson, C. Dunkel, I. Coste, K. Maisnier-Patin, A. Benoit de Coignac, J. P. Aubry, R. K. Lees, J. Y. Bonnefoy, H. R. MacDonald, and J. F. Gauchat. 2002. A role for CD147 in thymic development. J. Immunol. 168: 4946-4950.
12. Werlen, G., B. Hausmann, and E. Palmer. 2000. A motif in the ab T-cell receptor controls positive selection by modulating ERK activity. Nature 406: 422-426.
13. Dennis, J. W., I. R. Nabi, and M. Demetriou. 2009. Metabolism, cell surface organization, and disease. Cell 139: 1229-1241.
14. Bentzinger, C. F., K. Romanino, D. Cloëtta, S. Lin, J. B. Mascarenhas, F. Oliveri, J. Xia, E. Casanova, C. F. Costa, M. Brink, et al. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8: 411-424.
15. Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J. Qin, and B. Su. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137.
16. Michie, A. M., and J. C. Zúñiga-Pflücker. 2002. Regulation of thymocyte differentiation: pre-TCR signals and b-selection. Semin. Immunol. 14: 311-323.
17. D'Ambrosio, D., D. A. Cantrell, L. Frati, A. Santoni, and R. Testi. 1994. Involvement of p21ras activation in T cell CD69 expression. Eur. J. Immunol. 24: 616-620.
18. Wang, H., J. Holst, S. R. Woo, C. Guy, M. Bettini, Y. Wang, A. Shafer, M. Naramura, M. Mingueneau, L. L. Dragone, et al. 2010. Tonic ubiquitylation controls T-cell receptor:CD3 complex expression during T-cell development. EMBO J. 29: 1285-1298.
19. Yu, H., G. Kaung, S. Kobayashi, and R. R. Kopito. 1997. Cytosolic degradation of T-cell receptor a chains by the proteasome. J. Biol. Chem. 272: 20800-20804.
20. Gabison, E. E., T. Hoang-Xuan, A. Mauviel, and S. Menashi. 2005. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87: 361-368.
21. Chen, X., J. Su, J. Chang, T. Kanekura, J. Li, Y. H. Kuang, S. Peng, F. Yang, H. Lu, and J. L. Zhang. 2008. Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line. Cancer Invest. 26: 689-697.
22. Nabeshima, K., J. Suzumiya, M. Nagano, K. Ohshima, B. P. Toole, K. Tamura, H. Iwasaki, and M. Kikuchi. 2004. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J. Pathol. 202: 341-351.
23. Kerdiles, Y. M., D. R. Beisner, R. Tinoco, A. S. Dejean, D. H. Castrillon, R. A. DePinho, and S. M. Hedrick. 2009. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10: 176-184.
24. Ouyang, W., O. Beckett, R. A. Flavell, and M. O. Li. 2009. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30: 358-371.
25. Carrette, F., and C. D. Surh. 2012. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24: 209-217.
26. Lee, K., P. Gudapati, S. Dragovic, C. Spencer, S. Joyce, N. Killeen, M. A. Magnuson, and M. Boothby. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743-753.
27. Mao, C., E. G. Tili, M. Dose, M. C. Haks, S. E. Bear, I. Maroulakou, K. Horie, G. A. Gaitanaris, V. Fidanza, T. Ludwig, et al. 2007. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J. Immunol. 178: 5443-5453.
28. Juntilla, M. M., J. A. Wofford, M. J. Birnbaum, J. C. Rathmell, and G. A. Koretzky. 2007. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc. Natl. Acad. Sci. USA 104: 12105-12110.
29. Hinton, H. J., D. R. Alessi, and D. A. Cantrell. 2004. The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat. Immunol. 5: 539-545.
30. Kirk, P., M. C. Wilson, C. Heddle, M. H. Brown, A. N. Barclay, and A. P. Halestrap. 2000. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19: 3896-3904.
31. Le Floch, R., J. Chiche, I. Marchiq, T. Naiken, K. Ilc, C. M. Murray, S. E. Critchlow, D. Roux, M. P. Simon, and J. Pouysségur. 2011. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc. Natl. Acad. Sci. USA 108: 16663-16668.
32. Fang, M., Z. Shen, S. Huang, L. Zhao, S. Chen, T. W. Mak, and X. Wang. 2010. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143: 711-724.
33. Lau, K. S., E. A. Partridge, A. Grigorian, C. I. Silvescu, V. N. Reinhold, M. Demetriou, and J. W. Dennis. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129: 123-134.
34. Hagiwara, A., M. Cornu, N. Cybulski, P. Polak, C. Betz, F. Trapani, L. Terracciano, M. H. Heim, M. A. Rüegg, and M. N. Hall. 2012. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15: 725-738.
35. Masui, K., K. Tanaka, D. Akhavan, I. Babic, B. Gini, T. Matsutani, A. Iwanami, F. Liu, G. R. Villa, Y. Gu, et al. 2013. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 18: 726-739.